Aurobindo Pharma Limited — Others, 01-08-2025: News Verification

Aurobindo Pharma has addressed a media report concerning major drug companies receiving letters to lower prices, which reportedly caused a slump in pharma stocks. The company clarified it has not received any such communication. Aurobindo stated it is unaware of any negotiations or events that could explain recent share price movements, nor does it have any undisclosed price-sensitive information related to this report. This update reassures investors by denying the specific negative news item's applicability to the company's operations.